PFE
Pfizer Inc.
29.75
-
0.08
0.27%
30 x 29.78
30 x 29.77
bid
ask
30 @ 04:00 PM
29.77+0.02 (0.07%)
Bearish
237
Bullish
495
sentiment
29.73
day range
30.14
25.20
52 week range
34.11
Prev Close29.83
Open30.00
Low29.73
High30.14
Volume22.12M
Avg. Volume31.61M
Market Cap168.58B
Inst. Own67.63%
Beta0.62
Short Ratio2.11
Div & Yield1.68 / 5.63
EPS-0.46
P/E0.00
1yr Target29.99
50day MA29.27
200day MA28.13
Day Gain | ||
Gain | ||
Market Val | ||
Costs | ||
Cash | ||
Portfolio | ||
Realized | ||
Dividend |
News
...
Pfizer (NYSE:PFE) Shares Up 0.3% | news.google.com • |
3 Magnificent Dividend Stocks With Yields Above 5% to Buy Now and Hold Forever | fool.com • |
Edgestream Partners L.P. Raises Stake in Pfizer Inc. (NYSE:PFE) | news.google.com • |
Pfizer Inc. (PFE): Among the Best Stocks to Buy for Passive Income | news.google.com • |
Pfizer Inc. (PFE): Among the Best Stocks to Buy for Passive Income | news.google.com • |
ABBV: 3 High-Dividend Pharma Blue Chips That Are on Sale Right Now | news.google.com • |
Profile
...
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE, as well as has strategic clinical collaboration with Acepodia Inc. for the development of antibody-cell conjugation-based cell therapies in autoimmune diseases. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Earning
...
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-10-29 | 2024-09 | 0.63 | N/A | N/A | N/A |
2024-07-30 | 2024-06 | 0.45 | 0.6 | 0.15 | 33.33% |
2024-05-01 | 2024-03 | 0.56 | 0.82 | 0.26 | 46.43% |
2024-01-30 | 2023-12 | -0.19 | 0.1 | 0.29 | 152.63% |
2023-10-31 | 2023-09 | -0.32 | -0.17 | 0.15 | 46.88% |
2023-08-01 | 2023-06 | 0.56 | 0.67 | 0.11 | 19.64% |
Upgrade / Downgrade
...
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-10-16 | Wells Fargo | Upgrade | Equal-Weight | Equal-Weight |
2023-10-16 | Morgan Stanley | Upgrade | Equal-Weight | Equal-Weight |
2023-10-16 | Truist Securities | Upgrade | Buy | Buy |
2023-10-15 | Jefferies | Upgrade | Hold | Buy |
2023-10-15 | Wells Fargo | Upgrade | Equal-Weight | Equal-Weight |
2023-10-15 | JP Morgan | Upgrade | Neutral | Neutral |
Insider Holder
...
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2024-02-27 | BOSHOFF CHRISTOFFEL | Officer | 156.63K | Stock Award(Grant) |
2024-02-22 | BOURLA ALBERT | Chief Executive Officer | 332.49K | Conversion of Exercise of derivative security |
2024-08-12 | DAMICO JENNIFER B. | Officer | 8.58K | Sale |
2024-02-26 | DE GERMAY ALEXANDRE | Officer | 74.38K | Stock Award(Grant) |
2023-12-14 | GOTTLIEB SCOTT | Director | 9.00K | Purchase |
2024-02-22 | JOHNSON RADY A | Officer | 103.45K | Conversion of Exercise of derivative security |
Institution Ownership
...
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Group Inc | 508.09M | 18.64B | 9.00% |
2023-06-29 | Blackrock Inc. | 445.15M | 16.33B | 7.88% |
2023-06-29 | State Street Corporation | 287.20M | 10.53B | 5.09% |
2023-06-29 | Wellington Management Group, LLP | 233.11M | 8.55B | 4.13% |
2023-06-29 | Capital World Investors | 199.01M | 7.30B | 3.52% |
2023-06-29 | Geode Capital Management, LLC | 112.87M | 4.14B | 2.00% |
Fund Ownership
...
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Total Stock Market Index Fund | 176.05M | 6.46B | 3.12% |
2023-06-29 | Vanguard 500 Index Fund | 134.41M | 4.93B | 2.38% |
2023-05-30 | Fidelity 500 Index Fund | 62.81M | 2.39B | 1.11% |
2023-08-30 | SPDR S&P 500 ETF Trust | 62.20M | 2.20B | 1.10% |
2023-07-30 | Vanguard Specialized-Health Care Fund | 58.87M | 2.12B | 1.04% |
2023-08-30 | iShares Core S&P 500 ETF | 52.80M | 1.87B | 0.94% |
Dividend
...
Dividend | Date |
---|---|
0.42 | 2024-07-26 |
0.42 | 2024-07-25 |
0.42 | 2024-05-09 |
0.42 | 2024-01-26 |
0.42 | 2024-01-25 |
0.41 | 2023-11-10 |
Split
...
Split | Date |
---|---|
1054 : 1000 | 2020-11-17 |
3 : 1 | 1999-07-01 |
2 : 1 | 1997-07-01 |
2 : 1 | 1995-07-03 |
2 : 1 | 1991-04-01 |
2 : 1 | 1983-07-01 |
This topic has been deleted. Only users with topic management privileges can see it.
-
$PFE.. see you guys are flying today.. lol.. worse stock ever!
-
Worst stock ever! POS!
-
Shut up nobody here knows when this will go ️
-
-
-
Any other approval or news means nothing
-
-
+0.15 - what a rally!!!
-
+0.05 PM - this is basically PFE version of ‘to the moon’..
-
No Green Day bitch give me a green two days so I can sleep well
-
-
Come
On go negative baby -
Look at the charts. Only buy PFE when it dips far below the 200 sma. Pretty close to a buy now. Sell if it pops above the 50 day by 25%.
Repeat.
This stock can’t seem to sustain a gain.
-
If the news is good it’s going to 30$
-
$PFE
Are you joking??? It was up 5%???
Selling??? Are you that stupid???
Look at NVAX & MRNA above $100 a share
You guys are total idiots!!!!
-
Pfizer (NYSE:PFE) Shares Up 0.3%
news.google.com • -
Edgestream Partners L.P. Raises Stake in Pfizer Inc. (NYSE:PFE)
news.google.com • -
Pfizer Inc. (PFE): Among the Best Stocks to Buy for Passive Income
news.google.com • -
Pfizer Inc. (PFE): Among the Best Stocks to Buy for Passive Income
news.google.com • -
ABBV: 3 High-Dividend Pharma Blue Chips That Are on Sale Right Now
news.google.com • -
PFIZER INC : Jefferies gives a Buy rating
news.google.com • -
INTC, MSFT, META, PFE, TSLA: Top Trending Stocks Today- Benzinga
news.google.com • -
Beyond The Numbers: 13 Analysts Discuss Pfizer Stock
news.google.com • -
Is Pfizer Stock Going to $36? 1 Wall Street Analyst Thinks So.
news.google.com • -
Learn to Evaluate (PFE) using the Charts
news.google.com • -
5 Things to Know Before the Stock Market Opens
news.google.com • -
US stocks muted ahead of Fed meeting; Pfizer, Intel gain
news.google.com • -
PFE: 3 Healthcare Stocks With High Analyst Price Targets
news.google.com • -
Pfizer Inc. (PFE): A Bull Case Theory
news.google.com • -
Pfizer Stock Vs. AbbVie
news.google.com • -
Is Pfizer Inc. (PFE) The Most Buzzing Stock To Buy Now?
news.google.com •